Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GPN01020
- Development stage
- Phase 2
- Lead developer
- Central Hospital of Enshi Tujia and Miao Autonomous Prefecture
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
GPN01020 is a Class 1.1 innovative traditional Chinese medicine (TCM) capsule being developed by Grandpharma Beilin (Xi'an) Pharmaceutical (a subsidiary of Grand Pharmaceutical Group) in collaboration with Enshi Tujia and Miao Autonomous Prefecture Central Hospital. It is designed for the preventive treatment of migraine, specifically targeting patients with the TCM syndrome pattern of blood stasis obstruction or qi deficiency and blood stasis. Derived from a hospital preparation with over 20 years of clinical use, GPN01020 has demonstrated efficacy in reducing the frequency and duration of migraine attacks in early clinical studies. It is currently in Phase II clinical development in China.
- Other names
- GPN01020 capsulesGPN-01020 capsulesGPN 01020 capsulesGPN01020胶囊
Beyond the preview
Go deeper on GPN01020.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GPN01020.